Everything you need to know about the record CSL dividend

CSL's latest dividend is its biggest yet…

| More on:
Man holding out Australian dollar notes, symbolising dividends.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a bouncy but positive day for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares this Tuesday. After starting the week off on a strong footing yesterday, the ASX 200 is continuing that momentum today, with the index currently up 0.05%. But let's talk about what's happening with CSL Ltd (ASX: CSL) shares.

CSL shares are not faring as well as the broader market, to put it nicely. In fact, the ASX 200 healthcare giant is having an awful day.

Yesterday, the CSL share price closed at $308.93. But this morning, those same shares opened at just $300.03 and are currently trading at $296.37. That's down a hefty 4.07% for the day thus far.

It seems investors are not too impressed with the full-year earnings report that the company dropped this morning.

As we covered at the time, these earnings contained some fairly impressive figures. CSL reported an 11% bump in revenues for the 12 months to 30 June to US$14.8 billion.

That helped push the company's net profit after tax before amortisation (NPATA) up by 11% to US$2.91 billion, or up 15% to US$3.01 billion in constant currency terms.

As my Fool colleague covered after market open, it seems that investors may have been disappointed by CSL's guidance for FY2025. The company is expecting to record revenue growth of between 5-7% for the 12 months to 30 June 2025, and an NPATA of between US$3.2 and US$3.3 billion.

But let's talk about the supersized dividend that CSL has just revealed.

CSL ups its dividend to new record high

This morning, CSL revealed that its final dividend for FY2024 would come in at US$1.45 per share. That's a healthy 12.4% rise over the final dividend of US$1.29 ($2.01) per share that investors received last year, as well as a 21.85% increase over April's interim dividend of US$1.19 ($1.80) per share.

We don't yet know whether this latest payment will be in Australian dollars, but at today's exchange rates, US$1.45 would equate to approximately $2.20 per share. Like April's interim dividend, it will not come with any franking credits attached.

Nevertheless, this is a big deal for CSL, as this latest dividend represents a record-high shareholder payout for the company.

However, shareholders will have to wait a while until this passive income arrives in their bank accounts. CSL has scheduled Monday, 9 September next month as this payment's ex-dividend date. So anyone wishing to bag this payout will have to own CSL shares by market close on Friday, 6 September.

The payment date will then roll around on 2 October.

CSL's dividend reinvestment plan (DRP) is not operating for this payment, so shareholders have no other option than to receive a traditional cash payment.

At today's pricing, CSL shares have a trailing dividend yield of 1.28%. If we factor in the newly announced dividend, CSL would have a forward dividend yield of 1.35%.

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »